Farmacología y Toxicología
Fachbereich
Philips Healthcare España
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Philips Healthcare España (2)
2023
-
Longitudinal interplay between subclinical atherosclerosis, cardiovascular risk factors, and cerebral glucose metabolism in midlife: results from the PESA prospective cohort study
The Lancet Healthy Longevity, Vol. 4, Núm. 9, pp. e487-e498
-
Neutrophil β1 adrenoceptor blockade blunts stroke-associated neuroinflammation
British Journal of Pharmacology, Vol. 180, Núm. 4, pp. 459-478